Summary & Overview
HCPCS C1780: Intraocular Lens, New Technology
HCPCS Level II code C1780 designates a new-technology intraocular lens intended for implantation following cataract extraction or refractive lens procedures. As a specific HCPCS Level II device code, it identifies implants that differ from standard intraocular lenses based on novel design, materials, or clinical features. Nationally, such codes matter for device identification, coverage determination, and claims processing because payers may apply distinct coverage rules or prior authorization requirements for new-technology implants.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how C1780 is used on claims, payer coverage patterns, and the clinical context for intraocular lens implantation. Readers will find benchmarks for utilization where available, summaries of common payer policies and prior authorization considerations, and clinical context on when new-technology intraocular lenses are typically implanted (e.g., cataract surgery and refractive lens exchange).
This resource is intended to clarify the code purpose, common sites of service, and the areas stakeholders should review when billing and seeking coverage for newly categorized intraocular lenses. Data not available in the input will be explicitly noted in relevant sections.
Billing Code Overview
HCPCS Level II code C1780 represents intraocular lens technology classified as new technology. The code describes a lens implanted in the eye to replace the natural lens, typically associated with cataract extraction or refractive lens exchange procedures.
Service type: intraocular lens implantation (new technology)
Typical site of service: ambulatory surgical center or hospital outpatient setting, where cataract surgery and intraocular lens implantation are commonly performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 72-year-old patient with visually significant cataract presents to a tertiary ophthalmology clinic for cataract extraction with intraocular lens implantation. Preoperative evaluation includes manifest refraction, biometry (axial length and keratometry), corneal topography as indicated, specular microscopy if endothelial disease suspected, and discussion of lens options including standard monofocal, toric, multifocal, or a new technology intraocular lens billed under C1780 (Lens, intraocular (new technology)). On the day of surgery the patient undergoes phacoemulsification with posterior chamber intraocular lens implantation in an ambulatory surgery center or hospital outpatient department. Typical site of service is an ambulatory surgery center or hospital outpatient setting. Postoperative visits occur on postoperative day 1, week 1, and month 1 with refraction performed at the 4–6 week visit to determine final visual acuity and refractive outcome. The clinical workflow includes informed consent documenting the specific implanted lens model (new technology lens), operative note documenting lens model and lot number, appropriate device implant reporting to billing with C1780, and follow-up documentation of outcomes and any complications such as cystoid macular edema, posterior capsule opacification, or lens-related issues that could require YAG capsulotomy or lens exchange.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |